These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 16024754)

  • 1. Clinical pharmacology and differential cognitive efficacy of estrogen preparations.
    Gleason CE; Carlsson CM; Johnson S; Atwood C; Asthana S
    Ann N Y Acad Sci; 2005 Jun; 1052():93-115. PubMed ID: 16024754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review.
    Sherwin BB; Henry JF
    Front Neuroendocrinol; 2008 Jan; 29(1):88-113. PubMed ID: 17980408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical menopause, estrogen, and cognitive function in women: what do the findings tell us?
    Sherwin BB
    Ann N Y Acad Sci; 2005 Jun; 1052():3-10. PubMed ID: 16024746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen and progestogen effect on venous thromboembolism in menopausal women.
    Archer DF; Oger E
    Climacteric; 2012 Jun; 15(3):235-40. PubMed ID: 22612609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen: a neuroprotective or proinflammatory hormone? Emerging evidence from reproductive aging models.
    Sohrabji F
    Ann N Y Acad Sci; 2005 Jun; 1052():75-90. PubMed ID: 16024752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WHI and WHIMS follow-up and human studies of soy isoflavones on cognition.
    Zhao L; Brinton RD
    Expert Rev Neurother; 2007 Nov; 7(11):1549-64. PubMed ID: 17997703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics and efficacy of different estrogens are not equivalent.
    Ansbacher R
    Am J Obstet Gynecol; 2001 Feb; 184(3):255-63. PubMed ID: 11228470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related cognitive decline in the menopause: effects of hormone replacement therapy on cognitive event-related potentials.
    Anderer P; Saletu B; Gruber D; Linzmayer L; Semlitsch HV; Saletu-Zyhlarz G; Brandstätter N; Metka M; Huber J
    Maturitas; 2005 Jul; 51(3):254-69. PubMed ID: 15978969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and benefit considerations for menopausal hormone therapy.
    Pickar JH; Archer DF; Kagan R; Pinkerton JV; Taylor HS
    Expert Opin Drug Saf; 2017 Aug; 16(8):941-954. PubMed ID: 28664754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal hormone therapy: new questions and the case for new clinical trials.
    Manson JE; Bassuk SS; Harman SM; Brinton EA; Cedars MI; Lobo R; Merriam GR; Miller VM; Naftolin F; Santoro N
    Menopause; 2006; 13(1):139-47. PubMed ID: 16607110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen effects on the hippocampus and frontal lobes.
    Maki PM
    Int J Fertil Womens Med; 2005; 50(2):67-71. PubMed ID: 16334413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose estrogen therapy for prevention of osteoporosis: working our way back to monotherapy.
    Richman S; Edusa V; Fadiel A; Naftolin F
    Menopause; 2006; 13(1):148-55. PubMed ID: 16607111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hormone replacement therapy on cognitive aging and dementia risk in postmenopausal women: a review of ongoing large-scale, long-term clinical trials.
    Zec RF; Trivedi MA
    Climacteric; 2002 Jun; 5(2):122-34. PubMed ID: 12051107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research.
    Henderson VW
    Neuroscience; 2006; 138(3):1031-9. PubMed ID: 16310963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.
    Prentice RL; Langer RD; Stefanick ML; Howard BV; Pettinger M; Anderson GL; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
    Am J Epidemiol; 2006 Apr; 163(7):589-99. PubMed ID: 16484450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New products and regimens (since 2003).
    Panay N
    Climacteric; 2007 Oct; 10 Suppl 2():109-14. PubMed ID: 17882685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.